Addus HomeCare Co. (NASDAQ:ADUS) Receives Average Rating of “Buy” from Analysts

Addus HomeCare Co. (NASDAQ:ADUSGet Free Report) has earned an average rating of “Buy” from the eleven brokerages that are currently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell rating, eight have issued a buy rating and two have assigned a strong buy rating to the company. The average 1-year price target among analysts that have updated their coverage on the stock in the last year is $133.67.

A number of brokerages have recently commented on ADUS. Citizens Jmp upgraded shares of Addus HomeCare to a “strong-buy” rating in a research note on Monday, December 16th. Macquarie reissued an “outperform” rating and set a $139.00 price objective on shares of Addus HomeCare in a report on Monday, November 4th. KeyCorp began coverage on Addus HomeCare in a research note on Friday, October 11th. They issued an “overweight” rating and a $150.00 target price for the company. StockNews.com upgraded shares of Addus HomeCare from a “hold” rating to a “buy” rating in a research note on Wednesday, December 11th. Finally, JMP Securities assumed coverage on shares of Addus HomeCare in a report on Monday, December 16th. They issued an “outperform” rating and a $150.00 price target on the stock.

Get Our Latest Report on ADUS

Addus HomeCare Price Performance

ADUS opened at $125.35 on Wednesday. The company has a market capitalization of $2.27 billion, a PE ratio of 28.68, a price-to-earnings-growth ratio of 2.11 and a beta of 1.02. The business has a 50-day moving average of $125.37 and a 200-day moving average of $125.71. Addus HomeCare has a fifty-two week low of $85.94 and a fifty-two week high of $136.12.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last posted its earnings results on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, topping the consensus estimate of $1.28 by $0.02. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The firm had revenue of $289.80 million during the quarter, compared to analyst estimates of $289.42 million. During the same period in the previous year, the company earned $1.03 EPS. The company’s revenue for the quarter was up 7.1% on a year-over-year basis. On average, equities research analysts expect that Addus HomeCare will post 4.59 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, EVP Roberton James Stevenson sold 2,250 shares of the stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $121.00, for a total value of $272,250.00. Following the transaction, the executive vice president now directly owns 10,217 shares in the company, valued at $1,236,257. This represents a 18.05 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO R Dirk Allison sold 12,500 shares of Addus HomeCare stock in a transaction on Monday, November 25th. The stock was sold at an average price of $123.16, for a total transaction of $1,539,500.00. Following the sale, the chief executive officer now directly owns 141,897 shares of the company’s stock, valued at $17,476,034.52. This represents a 8.10 % decrease in their position. The disclosure for this sale can be found here. 4.60% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Addus HomeCare

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ADUS. Wasatch Advisors LP boosted its position in shares of Addus HomeCare by 11.8% during the third quarter. Wasatch Advisors LP now owns 1,043,240 shares of the company’s stock worth $138,782,000 after purchasing an additional 110,010 shares in the last quarter. Point72 Asset Management L.P. lifted its holdings in Addus HomeCare by 73.4% during the second quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company’s stock worth $86,598,000 after acquiring an additional 315,602 shares in the last quarter. Dimensional Fund Advisors LP lifted its holdings in Addus HomeCare by 0.8% during the second quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company’s stock worth $82,930,000 after acquiring an additional 5,421 shares in the last quarter. State Street Corp grew its stake in Addus HomeCare by 4.4% in the third quarter. State Street Corp now owns 663,610 shares of the company’s stock valued at $88,280,000 after acquiring an additional 27,990 shares during the period. Finally, Principal Financial Group Inc. increased its holdings in shares of Addus HomeCare by 17.5% in the third quarter. Principal Financial Group Inc. now owns 505,853 shares of the company’s stock worth $67,293,000 after acquiring an additional 75,409 shares in the last quarter. Institutional investors own 95.35% of the company’s stock.

About Addus HomeCare

(Get Free Report

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Further Reading

Analyst Recommendations for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.